Repligen | RGEN - Efectivo Y Equivalentes

Precio De Mercado
131.21
Cambio Diario
4.12 3.24%
Mensual
11.58%
Anual
-0.33%
Q2 Expectativa
116.82




Efectivo Y Equivalentes Cambio Fecha
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1B 103.43M 2025-09
Bio Techne USD 172.88M 27.92M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 326M 37M 2025-12
General Electric Aerospace USD 12.39B 109M 2025-12
Henry Schein USD 136M 9M 2025-09
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Pacific Biosciences Of California USD 279.51M 223.04M 2025-12
Pfizer USD 1.34B 295M 2025-09
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Standard Biotools USD 118.21M 11.2M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Waters USD 587.83M 128.71M 2025-12
West Pharmaceutical Services USD 791.3M 162.8M 2025-12